Opportunities and challenges surrounding weight loss drugs

Published: 15-Jan-2025

Referencing the company’s recent report on the obesity crisis during the next decade, Vicky Painter, Content Analyst at FMCG Gurus, reviews the drivers and hurdles in this dynamic sector

You need to be a subscriber to read this article.
Click here to find out more.

During the past year, awareness of GLP-1 drugs among consumers has grown exponentially. However, attitudes surrounding these injections are split: FMCG Gurus’ research has revealed that 41% of consumers hold a positive opinion whereas 40% have a negative one.

It’s important for manufacturers and marketers alike to understand where these perceptions are coming from and how consumer attitudes and behaviours will affect the market heading forward. 

Not yet a Subscriber?

This is a small extract of the full article which is available ONLY to premium content subscribers. Click below to get premium content on Nutraceutical Business Review.

Subscribe now Already a subscriber? Sign in here.

Trending Articles

  1. You need to be a subscriber to read this article.
    Click here to find out more.

You may also like